Specifications TableSubjectChemistry, BiologySpecific subject areaBiomolecule engineeringType of dataFigure, TableHow data were acquiredThe adsorbance change for enzyme activity assay was recorded with Biotek ELX 800 at room temperature.Data formatRaw and AnalyzedParameters for data collectionThe mixture of cell lysate of 20 μL and substrate of 180 μL containing both or one of final 2.0 mM 4NPS and final 0.20 mM 4NNPP in a well was agitated for 2.0 min at room temperature, to record the absorbance in 30 min after the total lagging time of 4.0 min.Description of data collectionFusion expression of ECAP with PAAS and its mutants in DE3; Protein bands after SDS-PAGE staining with Coomassie brilliant blue or antibodies following standard protocol; SDESA or separate single assay of ECAP and PAAS/mutant to derive their activity ratios.Data source locationChongqing Medical University, Chongqing 400016, ChinaData accessibilityData incorporated within this articleRelated research articleYaping Li, Huimin Chong, Xiang Zhang, Xiaolan Yang,\*, Fei Liao\*\
High-throughput screening of enzyme mutants by comparison of their activity ratios to an enzyme tag\
Analytical Biochemistry doi: [10.1016/j.ab.2019.113474](10.1016/j.ab.2019.113474){#intref0010}**Value of the Data**•The dataset in this report will facilitate understanding the validation and application of a new high-throughput screening strategy to mutants of an enzyme in a library \[[@bib1]\]. To recognize positive mutants in a library, this new screening strategy fuses enzyme/mutants with a tag enzyme to compare activity ratios of the enzyme/mutants to the tag enzyme in cell lysates of their fused forms, when such activity ratios have physical significance and are proportional to specific activities of the non-fused counterpart enzyme/mutants.•Re-analyses of these data will benefit researchers to develop a practical system of the new high-throughput screening strategy for directed evolution of an applicable enzyme.•The data in this report utilizes *Escherichia coli* alkaline phosphatase (ECAP) as the tag enzyme for fusion with *Pseudomonas Aeruginosa* arylsulfatase (PAAS) *via* a flexible linker. Through the analyses of the data of the activities of ECAP in lysates of both *Escherichia coli* BL21 (DE3) transformed with a blank plasmid and host cells transformed with the fused mutants of PAAS, a rational threshold of ECAP activities in cell lysates can be developed for physical significance of the activity ratios of their fused forms at a preset confidence limit. Meanwhile, with a focused library of PAAS mutants through saturated mutagenesis at M72, the data enable researchers to understand the proportionality between the activity ratios of PAAS/mutants to ECAP in cell lysates of their fused forms and specific activities of the non-fused counterpart PAAS/mutants.•The data in this report will provide insights on the application of the new screening strategy to the elucidation of sequence-activity relationship of an applicable enzyme.

1. Data description {#sec1}
===================

The data in this article provides information on how to develop an experimental system for HTP screening of mutants through the comparison of the activity ratios of an applicable enzyme and its mutants to a suitable enzyme tag in cell lysates of their fused forms ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}). Data supported validity of the proposed strategy and the advantage to recognize the positive mutant in each pair of PAAS/mutants during HTP screening and elucidate the sequence-activity relationship of PAAS in HTP mode ([Fig. 5](#fig5){ref-type="fig"}) (see [Scheme 1](#sch1){ref-type="fig"}).Fig. 1Three designed linkers for fusion expression of ECAP and PAAS.Fig. 1Fig. 2PAGE analyses of fragmentation patterns. Based on the Western blotting with polyclonal antibodies against PAAS, ECAP, monoclonal antibody against 6His tag, and Coomassie Blue R250 staining of polypeptides after SDS-PAGE in Fig. 1a, b, c, d in Ref. \[[@bib1]\], respectively, here are the detection of polypeptides after separation by PAGE. (a) Coomassie Blue R250 staining. (b) ECAP activity staining with 1-Naphthol phosphate. (c) PAAS activity staining with 4-Nitrophenylsulfate on the same gel used in (b) after staining of ECAP activities.Fig. 2Fig. 3Distributions of PAAS mutants after saturation mutagenesis at M72. \* represents the three termination codes.Fig. 3Fig. 4Association of activity ratios of the fused forms in cell lysates with specific activities of their purified non-fused counterparts.Fig. 4Table 1Thresholds of ECAP activities in cell lysates. Data for 140 individual clones transformed with the blank plasmid.Table 1PNS (405 nm)4NNPP (450 nm)Activity Ratio[a](#tbl1fna){ref-type="table-fn"}ΔA/minAfter correction ΔA/minActivity on 4NPS (U/L)ΔA/minAfter correction ΔA/minActivity on 4NNPP (U/L)−0.00184−0.00181−1.570.000500.000850.47−3.36−0.00165−0.00163−1.420.000450.000770.42−3.34−0.00112−0.00109−0.950.000500.000710.39−2.41−0.00113−0.00110−0.960.000450.000670.37−2.59−0.00076−0.00073−0.640.000500.000640.36−1.79−0.00183−0.00181−1.570.000290.000640.35−4.47−0.00118−0.00116−1.010.000400.000620.34−2.92−0.00106−0.00104−0.900.000390.000590.33−2.77−0.00100−0.00098−0.850.000390.000580.32−2.65−0.00131−0.00129−1.120.000330.000580.32−3.53−0.00104−0.00102−0.880.000350.000540.30−2.95−0.00117−0.00116−1.000.000300.000520.29−3.48−0.00122−0.00120−1.040.000290.000520.29−3.63−0.00112−0.00110−0.960.000310.000520.29−3.32−0.00077−0.00075−0.650.000370.000520.29−2.28−0.00087−0.00085−0.740.000350.000510.28−2.63−0.00110−0.00108−0.940.000300.000510.28−3.35−0.00098−0.00096−0.840.000320.000500.28−3.01−0.00115−0.00114−0.990.000280.000500.28−3.58−0.00089−0.00087−0.760.000330.000500.27−2.77−0.00088−0.00086−0.750.000330.000490.27−2.75−0.00056−0.00054−0.470.000380.000490.27−1.74−0.00082−0.00080−0.690.000330.000480.27−2.61−0.00109−0.00108−0.940.000260.000470.26−3.60−0.00107−0.00106−0.920.000260.000470.26−3.57−0.00091−0.00089−0.780.000290.000460.26−3.03−0.00110−0.00109−0.940.000250.000460.26−3.69−0.00047−0.00045−0.390.000370.000460.26−1.54−0.00011−0.00008−0.070.000440.000460.25−0.29−0.00102−0.00100−0.870.000260.000460.25−3.46−0.00064−0.00062−0.540.000330.000450.25−2.17−0.00083−0.00081−0.700.000290.000450.25−2.85−0.00063−0.00061−0.530.000320.000440.24−2.19−0.00101−0.00099−0.860.000250.000440.24−3.59−0.00105−0.00104−0.900.000240.000440.24−3.76−0.00028−0.00026−0.230.000380.000440.24−0.94−0.00038−0.00036−0.310.000350.000430.24−1.33−0.00036−0.00034−0.300.000350.000420.23−1.27−0.00074−0.00072−0.630.000280.000420.23−2.69−0.00049−0.00047−0.410.000330.000420.23−1.77−0.00038−0.00036−0.310.000350.000420.23−1.36−0.00080−0.00078−0.680.000260.000420.23−2.97−0.00068−0.00067−0.580.000280.000410.23−2.55−0.00063−0.00061−0.530.000290.000410.23−2.34−0.00048−0.00046−0.400.000320.000410.23−1.78−0.00078−0.00077−0.670.000250.000390.22−3.07−0.00105−0.00104−0.910.000190.000390.22−4.20−0.00100−0.00099−0.860.000190.000380.21−4.09−0.00071−0.00069−0.600.000250.000380.21−2.88−0.00074−0.00072−0.630.000240.000380.21−3.03−0.00131−0.00130−1.130.000130.000380.21−5.46−0.00110−0.00109−0.950.000160.000370.21−4.62−0.00043−0.00041−0.360.000290.000370.21−1.74−0.00099−0.00098−0.850.000180.000370.20−4.18−0.00058−0.00057−0.490.000250.000360.20−2.45−0.00066−0.00065−0.570.000240.000360.20−2.83−0.00034−0.00032−0.280.000290.000350.20−1.42−0.00072−0.00071−0.610.000220.000350.20−3.14−0.00060−0.00059−0.510.000240.000350.19−2.64−0.00052−0.00050−0.440.000250.000340.19−2.31−0.00045−0.00044−0.380.000250.000340.19−2.03−0.00074−0.00072−0.630.000200.000340.19−3.36−0.00076−0.00075−0.650.000190.000340.19−3.53−0.00073−0.00072−0.620.000190.000330.18−3.43−0.00048−0.00047−0.410.000240.000330.18−2.25−0.00067−0.00066−0.580.000190.000320.18−3.27−0.00037−0.00036−0.310.000250.000320.17−1.78−0.00037−0.00036−0.310.000250.000320.17−1.78−0.00022−0.00020−0.180.000270.000310.17−1.01−0.00025−0.00024−0.210.000260.000310.17−1.21−0.00054−0.00052−0.460.000210.000310.17−2.66−0.00052−0.00051−0.440.000210.000310.17−2.59−0.00050−0.00049−0.420.000210.000300.17−2.53−0.00035−0.00034−0.300.000240.000300.17−1.77−0.00085−0.00085−0.740.000140.000300.16−4.47−0.00065−0.00064−0.560.000170.000300.16−3.42−0.00045−0.00044−0.380.000210.000300.16−2.36−0.00029−0.00028−0.240.000240.000290.16−1.50−0.00034−0.00032−0.280.000230.000290.16−1.75−0.00040−0.00039−0.340.000210.000280.16−2.14−0.00020−0.00019−0.160.000250.000280.16−1.03−0.00028−0.00027−0.230.000230.000280.16−1.51−0.00033−0.00031−0.270.000220.000280.15−1.77−0.00037−0.00036−0.310.000210.000280.15−2.03−0.00055−0.00054−0.470.000170.000280.15−3.09−0.00035−0.00034−0.300.000210.000280.15−1.95−0.00015−0.00014−0.120.000250.000270.15−0.80−0.00005−0.00003−0.030.000260.000270.15−0.17−0.00009−0.00008−0.070.000250.000270.15−0.44−0.00033−0.00032−0.270.000210.000270.15−1.83−0.00013−0.00011−0.100.000250.000270.15−0.66−0.00051−0.00050−0.430.000170.000270.15−2.92−0.00012−0.00010−0.090.000250.000270.15−0.61−0.00045−0.00043−0.380.000180.000270.15−2.57−0.00045−0.00043−0.380.000180.000270.15−2.57−0.00053−0.00052−0.450.000160.000260.15−3.09−0.00047−0.00046−0.400.000170.000260.14−2.78−0.00055−0.00055−0.470.000150.000260.14−3.31−0.00029−0.00028−0.240.000200.000260.14−1.72−0.00029−0.00028−0.240.000200.000260.14−1.72−0.00037−0.00036−0.310.000180.000250.14−2.26−0.00016−0.00015−0.130.000220.000250.14−0.95−0.00021−0.00020−0.170.000210.000250.14−1.25−0.00025−0.00024−0.210.000200.000250.14−1.54−0.00010−0.00009−0.080.000230.000250.14−0.55−0.00056−0.00056−0.480.000140.000240.13−3.60−0.00031−0.00030−0.260.000180.000240.13−1.95−0.00040−0.00039−0.340.000160.000240.13−2.57−0.00015−0.00014−0.120.000210.000240.13−0.94−0.00025−0.00023−0.200.000180.000230.13−1.62−0.00062−0.00061−0.530.000110.000230.12−4.26−0.00047−0.00046−0.400.000140.000230.12−3.24−0.00046−0.00046−0.400.000140.000220.12−3.20−0.00026−0.00025−0.220.000170.000220.12−1.79−0.00035−0.00035−0.300.000150.000220.12−2.45−0.00011−0.00010−0.090.000190.000210.12−0.73−0.00010−0.00009−0.080.000190.000210.12−0.67−0.00053−0.00052−0.450.000110.000210.12−3.92−0.00035−0.00035−0.300.000140.000200.11−2.68−0.00033−0.00032−0.280.000140.000200.11−2.53−0.00051−0.00050−0.440.000100.000200.11−4.03−0.00045−0.00045−0.390.000110.000200.11−3.61−0.00003−0.00002−0.010.000180.000190.10−0.14−0.000010.000000.000.000180.000180.100.01−0.00015−0.00014−0.120.000150.000180.10−1.18−0.00045−0.00044−0.380.000090.000180.10−3.95−0.00018−0.00017−0.150.000140.000170.09−1.600.000210.000220.190.000210.000170.092.06−0.00022−0.00021−0.180.000130.000170.09−1.97−0.00014−0.00013−0.110.000130.000150.08−1.33−0.00005−0.00005−0.040.000140.000150.08−0.50−0.00004−0.00003−0.020.000140.000140.08−0.31−0.00047−0.00047−0.410.000050.000130.07−5.48−0.00031−0.00030−0.270.000070.000130.07−3.660.000040.000040.040.000140.000130.070.540.000470.000480.420.000180.000090.058.240.000560.000570.500.000190.000080.0510.74−0.00015−0.00014−0.120.000050.000070.04−3.080.000730.000740.640.000160.000030.0144.670.000550.000560.480.00005−0.00006−0.03−14.73[^2]Table 2Activity ratios of three fused forms *via* different linkers.Table 2Activity by SSA[b](#tbl2fnb){ref-type="table-fn"}Activity by SDESA[c](#tbl2fnc){ref-type="table-fn"}Activity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity Ratio[a](#tbl2fna){ref-type="table-fn"}Activity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity Ratio[a](#tbl2fna){ref-type="table-fn"}Cell lysate (*n* = 3)ECAP-dHis-PAAS2.17 ± 0.5320.36 ± 0.0826.01 ± 0.5972.04 ± 0.4150.34 ± 0.0726.07 ± 0.522ECAP-LHis-PAAS2.50 ± 0.6220.40 ± 0.0766.27 ± 0.7102.55 ± 0.4300.40 ± 0.0916.39 ± 0.403ECAP-LL-PAAS2.28 ± 0.5670.36 ± 0.0776.25 ± 0.6212.64 ± 0.3970.43 ± 0.0776.10 ± 0.389Purified enzyme (*n* = 3)ECAP-dHis-PAAS13.57 ± 3.022.22 ± 0.4706.11 ± 0.45712.67 ± 1.892.05 ± 0.4026.17 ± 0.321ECAP-LHis-PAAS13.33 ± 2.162.14 ± 0.3896.24 ± 0.39712.00 ± 2.7851.85 ± 0.57756.47 ± 0.774ECAP-LL-PAAS12.73 ± 2.032.03 ± 0.4216.29 ± 0.68712.54 ± 2.5742.00 ± 0.5106.26 0.440[^3][^4][^5]Table 3Comparison of two methods for cell lysis.Table 3Mutants[a](#tbl3fna){ref-type="table-fn"}Alkline lysis (*n* = 6)Sonication treatment (*n* = 6)PNS/4NNPPRelative value[b](#tbl3fnb){ref-type="table-fn"}PNS/4NNPPRelative value[b](#tbl3fnb){ref-type="table-fn"}ECAP-PAAS2.06 ± 0.0342.181.96 ± 0.0438.44ECAP-M72L1.68 ± 0.1034.311.45 ± 0.1128.33ECAP-M72T1.44 ± 0.0529.361.81 ± 0.1435.37ECAP-M72Q1.32 ± 0.0726.952.00 ± 0.0839.16ECAP-M72W1.19 ± 0.0124.371.41 ± 0.0427.54ECAP-M72V1.10 ± 0.0822.570.86 ± 0.0316.76ECAP-M72I1.02 ± 0.0920.921.35 ± 0.1426.51ECAP-M72A0.92 ± 0.0318.811.23 ± 0.1224.19ECAP-M72S0.69 ± 0.0414.200.55 ± 0.0310.76ECAP-M72P0.54 ± 0.0211.070.55 ± 0.0410.72ECAP-M72C0.49 ± 0.0110.070.76 ± 0.0214.87ECAP-M72H0.36 ± 0.047.390.43 ± 0.018.45ECAP-M72N0.28 ± 0.035.730.40 ± 0.027.91ECAP-M72Y0.26 ± 0.045.220.69 ± 0.0413.49ECAP-M72F0.25 ± 0.045.170.22 ± 0.014.39ECAP-M72D0.25 ± 0.035.020.32 ± 0.016.31ECAP-M72E0.15 ± 0.023.100.17 ± 0.013.39ECAP-M72K0.09 ± 0.031.870.12 ± 0.002.34ECAP-M72G0.08 ± 0.031.650.10 ± 0.011.86ECAP-M72R0.05 ± 0.021.000.05 ± 0.001.00[^6][^7]Table 4Association of activity ratios in cell lysates of the fused forms with specific activities of their non-fused counterparts based on ITA.Table 4MutantsSpecific activity by ITA (kU/g)Relative value[a](#tbl4fna){ref-type="table-fn"}Log~10~(Specific activity by ITA)log~10~ (Relative value)ECAP-PAAS14.6054.361.161.74ECAP-M72L8.3535.370.921.55ECAP-M72T8.1839.160.911.59ECAP-M72Q7.1028.330.851.45ECAP-M72W7.0726.520.851.42ECAP-M72V5.0627.550.701.44ECAP-M72A4.9224.190.691.38ECAP-M72I4.9616.760.701.22ECAP-M72S3.6814.870.571.17ECAP-M72C3.4610.760.541.03ECAP-M72P3.6013.490.561.13ECAP-M72H2.4110.720.381.03ECAP-M72Y1.058.450.020.93ECAP-M72D1.847.910.270.90ECAP-M72E0.456.31−0.340.80ECAP-M72N1.424.390.150.64ECAP-M72G1.183.400.070.53ECAP-M72F0.312.34−0.500.37ECAP-M72K0.591.86−0.230.27ECAP-M72R0.121.00−0.930.00[^8]Table 5Association of activity ratios in cell lysates of the fused forms with specific activities of their non-fused counterparts after affinity purification.Table 5Activity of non-fused PAAS/mutantActivity by SSA of ECAP-PAAS/mutant[c](#tbl5fnc){ref-type="table-fn"}Activity by SDESA of ECAP-PAAS/mutant[d](#tbl5fnd){ref-type="table-fn"}Specific activity (kU/g)Relative value[b](#tbl5fnb){ref-type="table-fn"}Activity Ratio[a](#tbl5fna){ref-type="table-fn"}Relative value[b](#tbl5fnb){ref-type="table-fn"}Activity Ratio[a](#tbl5fna){ref-type="table-fn"}Relative value[b](#tbl5fnb){ref-type="table-fn"}PAAS14.0912.36.2411.35.2012.8M72Q4.704.12.053.71.603.9G138S3.162.81.122.00.781.9M72D1.151.00.550.4051.0[^9][^10][^11][^12]Table 6Activities and activity ratios in cell lysates of tested PAAS/mutants in fused forms by either SSA or SDESA.Table 6Activity by SSA of ECAP -PAAS/mutants[c](#tbl6fnc){ref-type="table-fn"} (*n* = 120)Activity by SDESA of ECAP -PAAS/mutants[d](#tbl6fnd){ref-type="table-fn"} (*n* = 120)Activity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity Ratio[a](#tbl6fna){ref-type="table-fn"}Relative value[b](#tbl6fnb){ref-type="table-fn"}Activity on 4NPS (kU/g)Activity on 4NNPP (kU/g)Activity Ratio[a](#tbl6fna){ref-type="table-fn"}Relative value[b](#tbl6fnb){ref-type="table-fn"}ECAP-PAASMean0.0240.0046.23711.30.0200.0045.20112.8SD0.0060.0011.2290.0040.0011.041cv23%19%20%21%18%20%ECAP-M72QMean0.0140.0072.0523.70.0100.00651.6003.9SD0.0050.0020.3220.0040.0020.232cv35%27%16%35%29%15%ECAP-G138SMean0.0090.0081.1172.00.0070.0080.7801.9SD0.0030.0030.2280.0020.0030.129cv33%41%20%34%31%17%ECAP-M72Dmean0.0060.0110.5531.00.0040.0100.4051.0SD0.0010.0030.0790.0010.0030.053cv19%27%14%21%28%13%[^13][^14][^15][^16]Table 7One-way ANOVA for statistical analysis of activity ratios determined in HTP mode for paired fused PAAS/mutants.Table 7ECAP-G138SECAP-M72QANOVA Result of 4PNS/4NNPP between SSA and SDESAANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESAANOVA Result of 4PNS/4NNPP between SSA and SDESAANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESABetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalSum of Squares6.3167.53613.8520.52929.85430.38312.2318.74930.9793.3379.42682.756df1220221122022112382391238239Mean Squares6.3160.0340.5290.13612.230.0793.330.334F184.373.895155.2519.978Sig.0.0000.0500.0000.002ECAP-PAASECAP-M72DANOVA Result of 4PNS/4NNPP between SSA and SDESAANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESAANOVA Result of 4PNS/4NNPP between SSA and SDESAANOVA Result of 4PNS/4NNPP ratio to M72D between SSA and SDESABetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalBetween GroupsWithin GroupsTotalSum of Squares60.137287.826347.963133.7311280.6261414.3571.2060.992.19504.1144.114df1222223122222312202211220221Mean Squares60.1371.297133.7315.7691.2060.00400.019F46.38423.183268.0290Sig.0.0000.0000.0000.993[^17]Fig. 5ROC analyses of the recognition of hits in fused PAAS versus fused M72Q.Fig. 5Scheme. 1The expression vector map and active proteolytic fragments of fused forms. (a) The expression vector map. (b) Active proteolytic fragments of fused forms.Scheme. 1

The lane of the same label in figures stood for the same sample, as follows. M: molecular weight markers; 0. Transformed with empty plasmid; 1. Purified ECAP; 2. Purified PAAS; 3. Purified ECAP-dHis-PAAS; 4. Purified ECAP-LHis-PAAS; 5. Purified ECAP-LL-PAAS; 6. ECAP-dHis-PAAS in lysate; 7. ECAP-LHis-PAAS in lysate; 8. ECAP-LL-PAAS in lysate.

2. Experimental design, materials and methods {#sec2}
=============================================

2.1. Experimental design {#sec2.1}
------------------------

The comparison of the activity ratios of an applicable enzyme and its mutants to a suitable enzyme tag in cell lysates of their fused forms for HTP screening of mutants requires both the negligible or consistent impacts of the enzyme tag on the activities of enzyme/mutants and the proportionality of the activities of the enzyme tag in cell lysates of the fused enzyme/mutants to protein quantities of the active forms of the fused enzyme/mutants in both their native and partially-fragmented fused states. With ECAP as the tag fused to the *N*-terminus of PAAS and its mutants *via* a flexible linker, the proposed strategy was tested.

3. Materials and methods {#sec3}
========================

For each fused enzyme/mutant, an individual clone was transferred into 0.50 mL LB medium in 48-well microplate for amplification in 12 h at 37 °C and 180 rpm till optical density of 0.4--0.6 at 600 nm. Afterwards, each enzyme/mutant was induced for expression with 1.0 mM IPTG for 21 h at 15 °C. The lysates of fused mutants were prepared through alkaline lysis, unless otherwise stated. In detail, cell suspension of 20 μL from a well was transferred to a new well for mixing with 180 μL of the alkaline lysis buffer (1.0 M Tris-HCl at pH 9.0, plus 1.0 mM PMSF and 2.5 mM 4-aminobenzamidine) in 96-well microplates; the resulting mixture was agitated rapidly on Qilinbeier QB-9001 agitator for 4 h at room temperature to yield a cell lysate.

The substrate solution containing 2.0 mM 4NPS and/or 0.20 mM 4NNPP was utilized to monitor the absorbance change at 405 and/or 450 nm (The substrate solution containing both substrates was utilized for spectrophotometric-dual-enzyme-simultaneous-assay (SDESA) of ECAP and PAAS/mutant \[[@bib2],[@bib3]\]). For HTP assay of enzyme activity(ies), cell lysate of 20 μL was mixed with a substrate solution of 180 μL in 96-well microplates. The mixtures in wells were agitated for 2.0 min at room tempearture; after a total lagging time of 4.0 min, the absorbance of each well was recorded in 30 min at room tempearture to estimate initial rate for enzyme activity by linear regression with the preset absorptivity of 12 (mmol)^−1^·L^−1^·cm^−1^ for 4-nitrophenol and 19 (mmol)^−1^·L^−1^·cm^−1^ for 4-nitro-1-naphthol considering the light path. The change of absorbance of no less than 0.003 in 10 min was taken as the detection limit of enzyme activity, after the correction of the overlapped absorbance of chromogenic products during SDESA.

The activity ratio of PAAS/mutant to ECAP was the percentage of PAAS/mutant activity on 4NPS to ECAP activity on 4NNPP. Receiver-operating-characteristic (ROC) analysis yielded the area-under-the-curve (AUC) for the recognition of the one of higher activity in a pair.
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[^1]: These two authors contributed equally to this work.

[^2]: Activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

[^3]: Activities were determined by SSA/SDESA, with proteins quantified by Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

[^4]: SSA indicates separate single assay, one-by-one, in two solution.

[^5]: SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay.

[^6]: Paired *t*-test was applied to the comparison of relative values of activity ratios to ECAP between two lysis methods, giving *t* = 1.496, *P* = 0.15.

[^7]: Relative value was derived as the activity ratio to that of M72R.

[^8]: Relative value was derived as the activity ratio to that of M72R.

[^9]: Activities were determined by SSA/SDESA, with proteins quantified by the Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

[^10]: Relative value was derived as the ratio to that ofM72D in the non-fused or fused form.

[^11]: SSA indicates separate single assay, one-by-one, in two solution.

[^12]: SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay.

[^13]: Activities were determined by SSA/SDESA, with proteins quantified by Bradford method, activity ratio was the activity of PAAS/mutant to that of ECAP in their fused form.

[^14]: Relative value was derived as the ratio to that of M72D in fused form.

[^15]: SSA indicates separate single assay, one-by-one, in two solution.

[^16]: SDESA indicates spectrophotometric-dual-enzyme-simultaneous-assay.

[^17]: SSA: separate single assay. SDESA: spectrophotometric-dual-enzyme-simultaneous-assay.
